ArticleInfection and drug resistance2025
High Prevalence of Antimicrobial Prescribing Among Public Health Facilities in Central Uganda: Findings from Point Prevalence Survey.
Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Antibiotic prescribing practices of community health extension workers in East Central Uganda: an exploratory qualitative study.BMJ open · 2026Article
- Antibiotic Prescribing in Hospitalized Pediatric Patients Before Implementation of a Syndromic Antibiogram at Maputo Central Hospital, Mozambique.Pediatric reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Antimicrobial resistance (AMR) is the number one cause of death globally, and Sub-Saharan Africa bears the most significant burden. Previous studies conducted in Uganda have revealed high rates of antimicrobial prescribing in hospitals, with evidence of widespread inappropriate use, which necessitates the development of targeted interventions. The inappropriate use of antimicrobials is a driver of AMR. We conducted point-prevalence surveys of antimicrobial prescribing in selected health facilities in central Uganda to identify areas for improvement. Methods: The study utilised the Global Point Prevalence Survey (GPPS) to collect data on antimicrobial prescribing among eight public health facilities in Central Uganda from February to April 2024. Both inpatient and outpatient data were collected in three hospitals and five lower-level health facilities, respectively. The data collection tools adopted from GPPS were employed. Data were collected on patient demographics, antimicrobial therapy details, and compliance with standard treatment guidelines. Results: The overall prevalence of antimicrobial use among inpatients at the hospitals was 87.2%, and ceftriaxone was the most frequently prescribed antimicrobial, accounting for 30.6% of the prescriptions. Prescriptions for prophylactic use were the most predominant, with prophylaxis for obstetric and gynaecological surgery accounting for 30.7% of the prescriptions. The prevalence of antimicrobial use among outpatients at lower-level health facilities was 60.7%. Amoxicillin was the most prescribed antimicrobial across the sites, accounting for 39.1% of the prescriptions. Upper respiratory tract infections accounted for most prescriptions (45.1%). Standard treatment guideline compliance was nearly half (50.5%) among hospitals, with variations observed among the different study sites. Conclusion: A high prevalence of antimicrobial prescribing was observed, highlighting the need to enhance antimicrobial stewardship practices in health facilities. Compliance with standard treatment guidelines was average among hospitals but high among the lower-level health facilities. Some of the potential areas for stewardship interventions include broad-spectrum antibiotic prescriptions, prolonged antibiotic prophylactic courses, and inappropriate prescription of antibiotics for upper respiratory tract infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.